Bavachin exerted anti-neuroinflammatory effects by regulation of A20 ubiquitin-editing complex.

• Bavachin can inhibit TNF-α, IL-6, IL-1β and NLRP3 expression level. • Bavachin can upregulate the expression of A20 in microglial cells. • Bavachin can promote the assemble of A20 ubiquitin-editing complex. • Upregulation of A20 was involved in the inhibitory effects of bavachin on microglia activation via inhibition of NF-κB pathway. Neuroinflammation is a major pathophysiological contributor to the progression of the central nervous system disorders. Bavachin is a natural product belonging to the flavonoid class. The anti-neuroinflammatory effect and the molecular mechanisms are not well understood. In this study, we found bavachin can exert anti-neuroinflammatory effect via inhibition of nuclear factor-kappa B (NF-κB) signaling. We found that bavachin can obviously upregulate the expression of A20 (TNFAIP3) in microglial cells. Further studies suggested siRNA-A20 knockdown treatment can attenuate the inhibitory effects of bavachin on neuroinflammation. We further found bavachin can increase the interaction of ubiquitin-editing enzyme A20 complex including A20, Tax1-binding protein 1 (TAX1BP1) and Itch, the subsequently downregulated the K63-ubiquitination of TNF receptor associated factor 6 (TRAF6) and NF-κB signaling pathway. Altogether, our results indicated that bavachin exerted anti-neuroinflammatory effects through inhibition of NF-κB signaling mediated by regulation of ubiquitin-editing enzyme A20 complex. Our finding has important clinical significance for the potential application of bavachin in the treatment of neurological disorders. [ABSTRACT FROM AUTHOR]